MedPath

Juice Plus Supplement Clinical Trial

Not Applicable
Conditions
Cognitive Impairment
Alzheimer Disease, Early Onset
Mild Cognitive Impairment
Interventions
Dietary Supplement: Juice Plus+
Registration Number
NCT04656860
Lead Sponsor
University of Alabama, Tuscaloosa
Brief Summary

The study is designed to determine whether encapsulated fruit and vegetable juice concentrates can improve biological indicators of cognitive and multiple dimensions of memory and learning.

Detailed Description

Preventive interventions that delay the onset of mild cognitive impairment and benign forgetfulness have the potential to delay or even prevent the onset of Alzheimer's disease. However, few studies have examined the feasibility of Encapsulated Fruit and Vegetable Juice Concentrates in robust clinical trials; this limitation prevents investigators from determining the real value of these supplements. Therefore, we propose to enroll 150 adults aged 55 and older to a 24-month randomized placebo-controlled trial. Participants enrolled in the experimental condition will be encouraged to consume 6 Encapsulated Fruit and Vegetable Juice Concentrates capsules per day and 33 grams of a soy-based beverage power per day, which included 5 grams of fiber. Participants enrolled in the controlled condition will receive six placebo capsules and encouraged to maintain an adequate diet. Primary outcomes will include objective measures of cognition, and a panel of inflammatory markers, peptides, enzymes, and other biological markers known to be associated with cognitive decline.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
150
Inclusion Criteria
  • • Men and women ≥55 years old will be eligible participants
Exclusion Criteria
  • Prior neurological or psychiatric condition

  • Using medications or supplements that influence cognition or inflammation (e.g., nootropics, asprin, and Nonsteroidal anti-inflammatory drugs,),

  • Prior cancer diagnosis,

  • Major respiratory, kidney, liver, and gastrointestinal issues

  • Currently enrolled in a weight loss program or taking an appetite suppressant;

  • Current smokers or excessive alcohol users

  • Consume >= 4 servings of fruits and vegetables per day

    • Participate in >= 90 minutes of purposeful physical activity per week
    • Do not have a mobile phone
    • Do not have a data plan or regular wireless network

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PlaceboJuice Plus+Participants will consume 6 capsules daily consisting of microcrystalline cellulose, rice starch, vegetarian capsule (cellulose), and magnesium stearate. Participants in this condition will receive 1-year of supplements after the study is completed.
Juice Plus+Juice Plus+Participants will consume 6 capsules daily consisting of a combination of Juice Plus+ Garden Blend, Juice Plus+ Orchard Blend and Juice Plus+ Berry Blend. Participants will consume supplements for 24-months.
Primary Outcome Measures
NameTimeMethod
Change in Interleukin -5Baseline, Year, 1, and Year 2.

Interleukin -5 pg/mL

Change in serum Amyloid ABaseline, Year, 1, and Year 2.

Serum Amyloid A pg/mL

Change in Interleukin 6Baseline, Year, 1, and Year 2.

Interleukin 6 pg/mL

Change in C-reactive proteinBaseline, Year, 1, and Year 2.

C-reactive protein pg/mL

Secondary Outcome Measures
NameTimeMethod
Auditory Very Learning TestBaseline, 6-months, 12-months, 18-months, and 24-months

Computer automated verbal memory recognition task

Stroop TestBaseline, 6-months, 12-months, 18-months, and 24-months

Verbal interference

Trial Making taskBaseline, 6-months, 12-months, 18-months, and 24-months

Information processing speed

Trial Locations

Locations (2)

University of Alabama

🇺🇸

Tuscaloosa, Alabama, United States

University of Alabama, North East Medical Building

🇺🇸

Tuscaloosa, Alabama, United States

© Copyright 2025. All Rights Reserved by MedPath